Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy and safety of treatment with dutasteride and
tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement
of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic
Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits).
Transrectal ultrasound (TRUS) is done annually.